55 related articles for article (PubMed ID: 38410324)
1. True predictor of postoperative acute exacerbation of idiopathic interstitial pneumonia in lung cancer patients.
Wang Y; Bao Z
Surg Today; 2024 Jun; ():. PubMed ID: 38862631
[No Abstract] [Full Text] [Related]
2. Correction: Increased mortality in patients with RA-associated interstitial lung disease: data from a french administrative healthcare database.
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38290772
[No Abstract] [Full Text] [Related]
3. Acute exacerbations of fibrotic interstitial lung disease.
Churg A; Wright JL; Tazelaar HD
Histopathology; 2011 Mar; 58(4):525-30. PubMed ID: 20854464
[TBL] [Abstract][Full Text] [Related]
4. Algorithms Identifying Patients With Acute Exacerbation of Interstitial Pneumonia and Acute Interstitial Lung Diseases Developed Using Japanese Administrative Data.
Anan K; Kataoka Y; Ichikado K; Kawamura K; Yasuda Y; Hisanaga J; Nitawaki T; Yamamoto Y
Cureus; 2024 Jan; 16(1):e53073. PubMed ID: 38410324
[TBL] [Abstract][Full Text] [Related]
5. The Accuracy of Japanese Administrative Data in Identifying Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
Anan K; Kataoka Y; Ichikado K; Kawamura K; Johkoh T; Fujimoto K; Tobino K; Tachikawa R; Ito H; Nakamura T; Kishaba T; Inomata M; Yamamoto Y
Ann Clin Epidemiol; 2022; 4(2):53-62. PubMed ID: 38504851
[TBL] [Abstract][Full Text] [Related]
6. Expanded acceptance of acute exacerbation of nonspecific interstitial pneumonia, including 7 additional cases with detailed clinical pathologic correlation.
Miyamoto A; Sharma A; Nishino M; Mino-Kenudson M; Matsubara O; Mark EJ
Pathol Int; 2018 Jul; 68(7):401-408. PubMed ID: 29726062
[TBL] [Abstract][Full Text] [Related]
7. [Acute exacerbation of usual interstitial pneumonia and nonspecific interstitial pneumonia: analysis of 6 cases].
Tian XL; Xu WB; Shi JH; Feng RE; Xu ZJ; Liu HR; Wang MZ; Xu F; Huang H; Zhu YJ
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Apr; 31(4):255-9. PubMed ID: 18846960
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of validated methods for identifying pulmonary fibrosis and interstitial lung disease using administrative and claims data.
Jones N; Schneider G; Kachroo S; Rotella P; Avetisyan R; Reynolds MW
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():256-60. PubMed ID: 22262614
[TBL] [Abstract][Full Text] [Related]
9. Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study.
Raghu G; Flaherty KR; Lederer DJ; Lynch DA; Colby TV; Myers JL; Groshong SD; Larsen BT; Chung JH; Steele MP; Benzaquen S; Calero K; Case AH; Criner GJ; Nathan SD; Rai NS; Ramaswamy M; Hagmeyer L; Davis JR; Gauhar UA; Pankratz DG; Choi Y; Huang J; Walsh PS; Neville H; Lofaro LR; Barth NM; Kennedy GC; Brown KK; Martinez FJ
Lancet Respir Med; 2019 Jun; 7(6):487-496. PubMed ID: 30948346
[TBL] [Abstract][Full Text] [Related]
10. Validity of diagnoses of respiratory diseases recorded in a Japanese administrative database.
Awano N; Urushiyama H; Yamana H; Yokoyama A; Ando T; Izumo T; Inomata M; Ito Y; Jo T
Respir Investig; 2023 May; 61(3):314-320. PubMed ID: 36868080
[TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.
Naccache JM; Jouneau S; Didier M; Borie R; Cachanado M; Bourdin A; Reynaud-Gaubert M; Bonniaud P; Israël-Biet D; Prévot G; Hirschi S; Lebargy F; Marchand-Adam S; Bautin N; Traclet J; Gomez E; Leroy S; Gagnadoux F; Rivière F; Bergot E; Gondouin A; Blanchard E; Parrot A; Blanc FX; Chabrol A; Dominique S; Gibelin A; Tazi A; Berard L; Brillet PY; Debray MP; Rousseau A; Kerjouan M; Freynet O; Dombret MC; Gamez AS; Nieves A; Beltramo G; Pastré J; Le Borgne-Krams A; Dégot T; Launois C; Plantier L; Wémeau-Stervinou L; Cadranel J; Chenivesse C; Valeyre D; Crestani B; Cottin V; Simon T; Nunes H;
Lancet Respir Med; 2022 Jan; 10(1):26-34. PubMed ID: 34506761
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.
Raghu G; Remy-Jardin M; Ryerson CJ; Myers JL; Kreuter M; Vasakova M; Bargagli E; Chung JH; Collins BF; Bendstrup E; Chami HA; Chua AT; Corte TJ; Dalphin JC; Danoff SK; Diaz-Mendoza J; Duggal A; Egashira R; Ewing T; Gulati M; Inoue Y; Jenkins AR; Johannson KA; Johkoh T; Tamae-Kakazu M; Kitaichi M; Knight SL; Koschel D; Lederer DJ; Mageto Y; Maier LA; Matiz C; Morell F; Nicholson AG; Patolia S; Pereira CA; Renzoni EA; Salisbury ML; Selman M; Walsh SLF; Wuyts WA; Wilson KC
Am J Respir Crit Care Med; 2020 Aug; 202(3):e36-e69. PubMed ID: 32706311
[No Abstract] [Full Text] [Related]
13. Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial.
Kondoh Y; Azuma A; Inoue Y; Ogura T; Sakamoto S; Tsushima K; Johkoh T; Fujimoto K; Ichikado K; Matsuzawa Y; Saito T; Kishi K; Tomii K; Sakamoto N; Aoshima M; Araya J; Izumi S; Arita M; Abe M; Yamauchi H; Shindoh J; Suda T; Okamoto M; Ebina M; Yamada Y; Tohda Y; Kawamura T; Taguchi Y; Ishii H; Hashimoto N; Abe S; Taniguchi H; Tagawa J; Bessho K; Yamamori N; Homma S
Am J Respir Crit Care Med; 2020 May; 201(9):1110-1119. PubMed ID: 31917621
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
